DNA methylation inhibitors 5-aza-DC and RG108 reversed the function of suppressing RBPMS2 in GC cell malignant behaviors, implying that DNA methylation of RBPMS2 leads to the downregulation of RBPMS2 in GC, and thereby promoted tumor progression. This evidence concerns the gene RBPMS2 and neoplasm.